NASDAQ
Inovio Pharmaceuticals, Inc. (INO) has a free cash flow growth of -10.74% as of Friday, May 29, 2026. This represents a 418.46% decrease compared to its 12-month average of -2.07%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.